Home › Business & Finance › Hims & Hers struck a GLP-1 deal with Lilly. Its stock is...
Business & Finance

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
Key Points

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.
Hims & (ORG) Lilly (ORG) Hims (ORG) Zepbound (PERSON)
Originally published by MarketWatch Read original →